Connect with us

Health

Lingering lung disorders 5 years post-COVID: Here's what to know

Published

on

Lingering lung disorders 5 years post-COVID: Here's what to know

The COVID-19 pandemic engulfed the U.S. five years ago this month, leaving not only lingering mental health effects but also long-term physical symptoms.

One of those included a condition known as post-COVID pulmonary fibrosis, which involves scarring of the lungs that can worsen over time and may require a lung transplant, according to pulmonologists.

Early infection caused extensive inflammation in many different body systems, noted Dr. Scott Scheinin, MD, director of lung transplantation for Mount Sinai Health System in New York City.

SCIENTISTS FIND CLUES ON WHY COVID VACCINE CAUSES CHRONIC HEALTH PROBLEMS IN SOME

“Once they cleared that infection, a lot of people were left with some amount of lung tissue being destroyed,” Scheinin told Fox News Digital during an interview.

Advertisement

Post-COVID pulmonary fibrosis involves scarring of the lungs that can worsen over time and may require a lung transplant. (iStock)

Scheinin provided medical care on the frontlines in New York City in the first wave of the pandemic.

“The early COVID experience in New York was the worst thing I’ve ever experienced in my life. It was just horrible,” he recalled.

One patient’s story

One of Scheinin’s patients was a pastor in his mid-50s who was infected with COVID-19 in March 2020.

Pastor Benjamin Thomas of East Meadow, Long Island, spent nearly 100 days in the hospital — 54 of which were on a ventilator — and six weeks in a medically induced coma. 

Advertisement

5 YEARS AFTER COVID, AMERICANS ARE SPLIT ON WHETHER IT’S STILL A THREAT

He was discharged in July 2020 with an oxygen tank. Despite overcoming the initial infection, Thomas’ condition deteriorated. 

In 2022, the pastor noticed that his daily activity tolerance diminished dramatically and he required more oxygen for simple tasks.

Lung fibrosis

The inflammatory response sparked by early mutations of the novel coronavirus led to scarring of lungs in many individuals.  (iStock)

“I couldn’t take a shower for more than 30 seconds without being on oxygen,” he told Fox News Digital in an interview.

Scheinin said the pastor had no underlying conditions before contracting COVID. A lung biopsy showed that Thomas’ symptoms were consistent with post-inflammatory pulmonary fibrosis due to the COVID-19 infection.   

Advertisement

BOOST YOUR IMMUNE SYSTEM WITH THESE 8 SIMPLE STEPS — SOME MAY SURPRISE YOU

Thomas’ story was remarkable in that he survived the first bout with COVID, but two years later, his lungs had deteriorated so badly from the scarring that he needed a double lung transplant, Scheinin shared.

After spending seven months on the wait list, Thomas opted to settle for one lung since that would be faster than waiting for two. His surgery was performed on Feb. 28, 2023.

“The flu and any other illness would be exacerbated because of the underlying scarring of the lung.”

Now, two years after his lung transplant, Thomas says he no longer needs oxygen supplementation and is back to performing his daily pastoral activities at his church in Queens Village, New York, albeit at a slower pace than before. 

Advertisement

The pastor has returned to long-distance driving and can now walk for about 30 minutes. He attributes his successful recovery to the efforts of his Mount Sinai medical team, his faith and prayers from his congregation.

What is post-COVID fibrosis?

A healthy lung allows for the normal exchange of gases, such as oxygen and carbon dioxide, when one breathes air, Scheinin told Fox News Digital.

The inflammatory response sparked by early mutations of the novel coronavirus led to scarring of lungs in many individuals. 

CT lung scan

Testing for this condition is relatively non-invasive, typically including a cat scan or X-ray to check for structural lung damage, as well as blood tests and a pulmonary function test. (iStock)

In certain cases, the doctor said, the lungs no longer function as well as they did before the infection.

“The normal gas exchange is impeded because now you have areas of the lung tissue that are scarred, and therefore they’re not functioning normally,” he said. 

Advertisement

      

“If it’s a small area, it may be insignificant and unnoticeable, but as more of the lung tissue becomes scarred, more of the normal lung function is destroyed, [and] the patient becomes short of breath.” 

This could lead to future issues, especially if the patient is exposed to other respiratory ailments.

“The flu and any other illness would be exacerbated because of the underlying scarring of the lung,” Scheinin said. “I think it just makes the lungs more susceptible to injury.”

Symptoms, diagnosis and treatment

Symptoms of post-COVID pulmonary fibrosis can mimic other types of interstitial lung diseases, which are disorders that cause progressive scarring and inflammation of lung tissue.

Advertisement

If a person who previously had a COVID infection continues to experience shortness of breath, chronic cough and change in their exercise tolerance — or if they smoke or have an underlying condition such as emphysema — they should see their physician or a pulmonologist, according to Scheinin.

Oximeter

Risk factors for post-COVID pulmonary fibrosis typically include an underlying chronic condition, older age, and the use of mechanical ventilation during the acute phase of COVID. (iStock)

Testing for this condition is relatively non-invasive, typically including a cat scan or X-ray to check for structural lung damage, as well as blood tests and a pulmonary function test, the doctor told Fox News Digital.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Not everyone infected with COVID will develop pulmonary fibrosis, and the condition can vary in severity and recovery, the lung specialist noted. 

In some cases, a person may have been susceptible to developing lung fibrosis due to an underlying condition and the COVID-19 infection may accelerate the fibrotic progression.

Advertisement
Lung doctor

It is important to get checked out by a medical professional if you have symptoms, a lung specialist said, especially shortness of breath. (iStock)

It is important to get checked out by a medical professional if you have symptoms, Scheinin said, especially shortness of breath.

Risk factors for post-COVID pulmonary fibrosis typically include an underlying chronic condition, older age, and the use of mechanical ventilation during the acute phase of COVID, according to previous studies.

For more Health articles, visit www.foxnews.com/health

Researchers are investigating the use of antifibrotic medications to treat the condition, along with steroids and other anti-inflammatories that are currently used to treat other lung diseases.

Besides medications, treatment may also include pulmonary rehabilitation, exercise training and behavioral modifications, according to lung specialists.

Advertisement

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Health

Trump’s Focus on Punishing Drug Dealers May Hurt Drug Users Trying to Quit

Published

on

Trump’s Focus on Punishing Drug Dealers May Hurt Drug Users Trying to Quit

President Trump has long railed against drug traffickers. He has said they should be given the death penalty “for their heinous acts.” On the first day of his second term, he signed an executive order listing cartels as “terrorist organizations.”

But many public health and addiction experts fear that his budget proposals and other actions effectively punish people who use drugs and struggle with addiction.

The Trump administration has vowed to reduce overdose deaths, one of the country’s deadliest public health crises, by emphasizing law enforcement, border patrols and tariffs against China and Mexico to keep out fentanyl and other dangerous drugs. But it is also seeking huge cuts to programs that reduce drug demand.

The budget it submitted to Congress this month seeks to eliminate more than a billion dollars for national and regional treatment and prevention services. The primary federal agency addressing drug use, the Substance Abuse and Mental Health Services Administration, has so far lost about half its workers to layoffs under the Trump administration and is slated to be collapsed into the new Administration for a Healthy America, whose purview will reach far beyond mental illness and drug use.

And if reductions to Medicaid being discussed by Republicans in Congress are realized, millions of Americans will be unable to continue, much less start treatment.

Advertisement

The White House did not respond to requests for comment. The budget itself says that ending drug trafficking “starts with secure borders and a commitment to law and order” and that it is cutting addiction services deemed duplicative or “too small to have a national impact.”

Those cuts are agonizing, public health experts say, because they come just as the country is making sustained progress in lowering the number of fentanyl deaths. Many interventions may be contributing to that progress, including greater availability of the overdose reversal spray naloxone; more treatment beds, sober housing and peer counseling; and declines in the strength and quantity of the illicit drug supply, they say. But studies so far have not demonstrated convincingly which of those factors merit greater focus and investment.

“It would be a tragedy if we defund these programs without fully understanding what’s working and then our overdose rate starts to climb again,” said Dr. Matthew Christiansen, an addiction medicine physician in Huntington, W.Va., a city once labeled ground zero for the opioid crisis.

A letter signed by more than 320 behavioral medicine academic experts, sent Monday to congressional leaders, decried the cuts, including those to “community-based naloxone distribution, peer outreach programs, drug-use-related infectious disease prevention programs and drug test strip programs.”

The president’s budget calls for ending grants for “harm reduction,” a strategy to prevent disease transmission and keep drug users alive that has become largely accepted by mainstream addiction treatment providers.

Advertisement

The budget derides federal financial support for “dangerous activities billed as ‘harm reduction,’ which included funding ‘safe smoking kits and supplies’ and ‘syringes’ for drug users.”

That language is a callback to false reports in 2022 that a $30 million federal harm reduction grant could be used to purchase pipes for smoking crack and meth. In fact, a small portion of that grant, designated for “safer smoking kits,” was for supplies like alcohol swabs and lip balm. The grant also supported programs in states that permit sterile syringe exchanges, effective in reducing hepatitis C and H.I.V. infection rates.

“You can’t just tell people to stop using drugs with a snap of the fingers,” said Dr. Christiansen, a former director of West Virginia’s drug control policy. “These are tools to reduce the harm of opioids while also helping them be successful long-term.”

According to the federal agency’s annual survey of substance use, in 2023, 27.2 million Americans ages 12 or older had a drug use disorder, 28.9 million had alcohol use disorder, and 7.5 million had both.

The budget does leave intact block grants for states to combat addiction and mental illness. But without the agency’s additional grants, hands-on training and monitoring, in addition to possible Medicaid reductions, states will not be able to afford the many medical and social services required to prevent and treat addiction, Dr. Christiansen said.

Advertisement

David Herzberg, a professor of drug policy and history at the University at Buffalo, said that Mr. Trump’s almost single-minded linking of the nation’s drug problems with border issues harks back to late 19th-century America, when the government associated opium dens with Chinese immigrants. Fearing the incursion of Chinese workers and inflamed by press reports of Chinese men using opium to lure young white women into prostitution, Congress severely restricted Chinese immigration.

Then as now, Mr. Herzberg said, political conservatives found that targeting foreign drug suppliers was a muscular means of advancing broader agendas.

In contrast with highly publicized drug seizures, people who chronically use drugs have become afterthoughts, usually visible only as street irritants, their addiction perceived to be the result of their own choices, he said. Elected leaders who advocate for their welfare risk being tarred as soft on crime.

“If politicians are going to stick their necks out for them, I would be shocked,” Mr. Herzberg said.

Advertisement
Continue Reading

Health

FDA warns seniors to avoid this vaccine after deadly complications

Published

on

FDA warns seniors to avoid this vaccine after deadly complications

Older adults are being warned against receiving the chikungunya vaccine before traveling.

The Ixchiq vaccination, developed by Valneva to prevent the mosquito-borne chikungunya virus, was approved by the Food and Drug Administration (FDA) in November 2023 as the first of its kind.

Advertisement

The approval applies to anyone aged 18 and older who has a risk of being exposed to the virus.

FIRST VACCINE FOR CHIKUNGUNYA VIRUS, AN ‘EMERGING GLOBAL HEALTH THREAT,’ GETS FDA APPROVAL

But the FDA and the Centers for Disease Control and Prevention (CDC) released a safety notice on May 9 recommending that adults over 60 years old pause use of the vaccine due to fatal complications.

“FDA and CDC will continue the evaluation of post-marketing safety reports for Ixchiq,” the release reads. 

Older adults are being warned against receiving the chikungunya vaccine before traveling. (iStock)

Advertisement

“While the safety of Ixchiq for use in individuals 60 years of age and older is being further assessed, FDA and CDC are recommending a pause in use of the vaccine in this age group. FDA and CDC will update the public when the agencies complete their evaluation of this safety issue.”

The advisory follows reports of “serious adverse events,” including neurologic and cardiac events in people who received the vaccine.

    

Two of 17 events resulted in death from severe complications. One death was caused by encephalitis, or inflammation in the brain, the alert stated.

Those who experienced adverse effects of the vaccine were reported to be between the ages of 62 and 89.

Advertisement
A patient infected with chikungunya

A patient infected with chikungunya looks out from mosquito netting at the Clinicas Hospital in San Lorenzo, Paraguay, in March 2023. The FDA warned that Ixchiq, which contains a live, weakened version of the virus, may cause similar symptoms to chikungunya. (AP Photo/Jorge Saenz)

The FDA warned that Ixchiq, which contains a live, weakened version of chikungunya, may cause symptoms similar to the virus.

Typical symptoms of chikungunya include fever, severe joint pain, headache, muscle pain and a rash, according to the CDC. 

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Most people recover within a week, but some may experience “severe and disabling” joint pain for weeks or months. 

mosquito sucking blood from human

Chikungunya is spread by the bite of infected mosquitoes. (iStock)

“This virus is in a similar category as dengue or Zika and is carried by the same mosquitoes,” Fox News senior medical analyst Dr. Marc Siegel previously told Fox News Digital.

Advertisement

At the time of the vaccine’s approval, the FDA described chikungunya as an “emerging global health threat,” with at least five million cases reported over the past 15 years. 

For more Health articles, visit www.foxnews.com/health

The FDA plans to conduct an “updated benefit-risk assessment” for Ixchiq use in those over 60 years of age, according to the notice.

Fox News Digital’s Melissa Rudy contributed to this report.

Advertisement
Continue Reading

Health

Lose Weight up to 8x Faster With a ‘Green’ Diet for Fatty Liver

Published

on

Lose Weight up to 8x Faster With a ‘Green’ Diet for Fatty Liver


Advertisement


Diet for Fatty Liver: How to Lose Weight Faster and Easier | Woman’s World




















Advertisement











Advertisement




Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Trending